SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form POS EX - Post-effective amendment adding exhibits to registration statement [Rule 462(d)]:
SEC Accession No. 0001387131-19-005114
Filing Date
2019-07-16
Accepted
2019-07-16 17:04:17
Documents
3
Effectiveness Date
2019-07-16

Document Format Files

Seq Description Document Type Size
1 POST-EFFECTIVE AMENDMENT tnxp-posex_071619.htm POS EX 61197
2 OPINION OF BROWNSTEIN HYATT FARBER SCHRECK, LLP ex5-01.htm EX-5.01 13106
3 GRAPHIC ex5-01_img001.jpg GRAPHIC 16501
  Complete submission text file 0001387131-19-005114.txt   92880
Mailing Address 509 MADISON AVE. - SUITE 306 NEW YORK NY 10022
Business Address 509 MADISON AVE. - SUITE 306 NEW YORK NY 10022 1-800-849-7894
Tonix Pharmaceuticals Holding Corp. (Filer) CIK: 0001430306 (see all company filings)

IRS No.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
Type: POS EX | Act: 33 | File No.: 333-232195 | Film No.: 19957644
SIC: 2834 Pharmaceutical Preparations